1. No category

Wendell Gray Yarbrough, M.D.
Curriculum Vitae
Telephone #:
Office: (615) 322-6180
Fax #:
Office: (615) 343-9725
Date and Place of Birth:
May 31, 1963
Marital Status:
Married, Glenda Youngblood Yarbrough
2 children:
Gray Langley Yarbrough (11/14/92)
Miller Thomas Yarbrough (9/12/96)
Winston-Salem, North Carolina
Education:
1981-85
University of North Carolina, Chapel Hill, North Carolina
Degree: AB Chemistry with Honors & AB Zoology
John Motley Morehead Scholar
Class Rank: 5th of 3699
1985-1989
University of North Carolina School of Medicine
Chapel Hill, North Carolina
Degree: M.D. with Honors and Distinction, 1989
Postdoctoral Training:
1989-1990
Intern, Department of Surgery, University of North Carolina at Chapel
Hill, Chapel Hill, North Carolina.
1990-1994
Resident, Otolaryngology Head and Neck Surgery, University of North
Carolina at Chapel Hill, Chapel Hill, North Carolina.
1993-1994
Chief Resident, Otolaryngology/Head and Neck Surgery, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina.
1994-1996
Fellow Surgical Oncology, University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina.
Wendell G. Yarbrough, MD
2
Employment History:
7/2009-present
Co-leader, Thoracic and Head & Neck Program, Vanderbilt Ingram
Cancer Center, Nashville, Tennessee
4/2008-present
Adjunct Associate Professor Surgery, Meharry Medical College,
Nashville, Tennessee
9/2006-present
Ingram Professor of Cancer Research, Vanderbilt Ingram Cancer Center,
Vanderbilt University, Nashville, Tennessee
4/2003-present
Associate Professor with Tenure, Otolaryngology, Vanderbilt
University, Nashville, Tennessee
4/2003-present
Associate Professor with Tenure, Cancer Biology, Vanderbilt
University, Nashville, Tennessee
4/2003-present
Director, Barry Baker Laboratory of Head and Neck Oncology,
Department of Otolaryngology, Vanderbilt University, Nashville,
Tennessee
9/2003-9/2004
Chief Otolaryngology VA Medical Center, Nashville, TN
2001-2003
Associate Professor with Tenure, Curriculum in Genetics and Molecular
Biology University of North Carolina at Chapel Hill, Chapel Hill, North
Carolina.
2001-2003
Associate Professor with Tenure, Biochemistry & Biophysics University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
2001-2003
Associate Professor with Tenure, Otolaryngology/Head and Neck
Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North
Carolina.
2001
Assistant Professor Curriculum in Genetics and Molecular Biology
University of North Carolina at Chapel Hill, Chapel Hill, North
Carolina.
2000-2001
Assistant Professor, Biochemistry & Biophysics University of North
Carolina at Chapel Hill, Chapel Hill, North Carolina.
1996-2001
Assistant Professor, Otolaryngology/Head and Neck Surgery, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
1994-1996
Clinical Instructor, Otolaryngology/Head and Neck Surgery, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Wendell G. Yarbrough, MD
3
Medical Licensure:
Tennessee State License
37330
Board Certification:
Diplomat, American Board of Otolaryngology May 9, 1995
Certificate Number 3793
Professional Societies:
1987-present
Member, John B. Graham Student Research Society
1990-present
Member, American Academy of Otolaryngology
1992-2002
Member, American Laryngological, Rhinological, and Otological
Society
1994-present
Member, Nathan A. Womack Surgical Society
1994-present
Member, Newton Fisher Society
1996-present
Member, American Association for the Advancement of Science
1996-present
Member, American Association for Cancer Research
2000-present
Fellow, American College of Surgeons
2001-present
Member, American College of Surgeons Oncology Group (ACOSOG)
2002-present
Fellow, American Laryngological, Rhinological, and Otological Society
2002-2005
Vice-Chair, Head & Neck Organ Site Committee of the American
College of Surgeons Oncology Group (ACOSOG)
2002-2005
Chair, American College of Surgeons Oncology Group Translational
Research Subcommittee Head & Neck Organ Site Committee
2002-present
Member, Society of University Otolaryngologists-Head and Neck
Surgeons
2002-present
Fellow American Head and Neck Society
Grants Funded:
RC1, 9/30/09-8/31/11, National Cancer Institute. Human-in-Mouse
Modeling of HNSCC to Predict Response to Therapy. Wendell G.
Yarbrough, M.D. Principal Investigator, $776,167.
RC1, 9/22/09-8/31/11, National Institute of Dental & Craniofacial
Research. Development and Profiling of Human-in-Mouse Models of
Salivary Carcinomas. Wendell G. Yarbrough, M.D. Principal
Investigator, $641,453.
Cancer Center Support Grant (CCSG, PI, Jennifer Pietenpol), 7/1/09-
Wendell G. Yarbrough, MD
4
Grants Funded:
present, National Cancer Institute. Wendell G. Yarbrough Thoracic and
Head & Neck Program Co-Leader, $3,566,092
R01, 7/1/09-6/30/14, National Cancer Institute. The alpha 2 beta 1
integrin; Innate immunity to pathogens and tumors, Mary Zutter, PhD.
Principal Investigator, Wendell G. Yarbrough, M.D. Co-Investigator,
$1,250,000.
Vanderbilt Institute for Clinical and Translational Research (VICTR, PI,
Gordon Bernard), 5/2008. National Center for Research Resources,
National Institute of Health. Small equipment grant. Wendell
Yarbrough, M.D. Principal Investigator, $22,992.
Comprehensive Minority Institution /Cancer Center Partnership (U54,
PI, Harold Moses), 9/1/2007-8/31/2008. National Cancer Institute. Pilot
Project. Characterization of potential serum biomarkers in HNSCC.
Wendell G. Yarbrough, M.D. and Dana Marshall Ph.D., Co-Principal
Investigators, $100,000.
R21, 8/01/2007-7/31/2010, National Institute of Dental and Craniofacial
Research, Cortactin in HNSCC Tumor Progression. Alissa Weaver,
PhD. Principal Investigator, Wendell G. Yarbrough, M.D. CoInvestigator, $300,000.
Comprehensive Minority Institution /Cancer Center Partnership (U54,
PI, Harold Moses), 9/1/2006-8/31/2007. National Cancer Institute. PrePilot Project. Identification of serum biomarkers in HNSCC. Wendell G.
Yarbrough, M.D. and Sabina Francis M.D., Co-Principal Investigators,
$25,000.
Percy Memorial Research Award, 7/1/2006-6/30/2007. American
Academy of Otolaryngology-Head and Neck Surgery Foundation. Effect
of PI3K inhibition in HPV-associated HNSCC. Wendell G. Yarbrough,
M.D., Principal Investigator, $25,000.
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation Award,
9/1/2006-8/31/2007. Biomarkers for HNSCC and Targets for Novel
Therapies. Wendell G. Yarbrough, M.D., Principal Investigator,
$300,000.
Senior Investigator Award-Head and Neck Cancer Research, 7/1/2005
renewable yearly through 6/30/2009. Thyroid, Head and Neck Cancer
Foundation (THANC). Serum biomarkers for head & neck cancer.
Wendell G. Yarbrough, M.D., Principal Investigator, $50,000 per year.
R01, 5/1/05-4/31/10. National Institute of Dental and Craniofacial
Wendell G. Yarbrough, MD
5
Grants Funded:
Research. Novel protein regulator of tumor suppressor ARF & NF-B.
Wendell G. Yarbrough, M.D., Principal Investigator, $1,250,000.
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation Award,
7/1/2005-6/30/2006. Proteome Profiling of Human Serum. Wendell G.
Yarbrough, M.D., Principal Investigator, $50,000.
R21, 7/01/03-6/31/05. National Cancer Institute. Gene Expression as a
Predictor of Metastasis in HNSCC. Wendell G. Yarbrough, M.D.,
Principal Investigator, $200,000.
R01, 4/1/00-3/31/04. National Institute of Dental and Craniofacial
Research. ARF as a therapeutic agent in oral malignancies. Wendell G.
Yarbrough, M.D., Principal Investigator, $998,320.
Doris Duke Clinical Research Fellowship, 6/1/01- 5/30/02. Doris Duke
Charitable Foundation. ONYX 015 intratumoral phase III clinical trial
and preclinical studies of ARF armed oncolytic viral therapy for head
and neck cancer. Wendell G. Yarbrough, M.D., Mentor. Adam M.
Zanation, Recipient, $25,000.
Medical Alumni Endowment Research Grant 6/1/01-5/31/02. Medical
Alumni Endowment. Pre-clinical Studies of Tumor Suppressor ARF in
Organotypic Raft Modeled Head and Neck Cancer. Wendell G.
Yarbrough, M.D., Mentor. Adam M. Zanation, Recipient, $2,000.
Alpha Omega Alpha Research Fellowship, 4/1/01-4/1/02. Alpha Omega
Alpha National Medical Honor Society. ARF armed oncolytic viral
therapy for head and neck cancer: preclinical studies. Wendell G.
Yarbrough, M.D., Mentor. Adam M. Zanation, Recipient, $3,500.
Scott Neil Schwirck Fellowship, 1/1/01–1/01/02. UNC School of
Medicine. Preclinical studies of ARF tumor suppressor therapy for head
and neck cancer. Wendell G. Yarbrough, M.D., Mentor. Adam M.
Zanation, Recipient, $2,500
University Research Council, 1/00-12/01. University of North Carolina.
Development of a Smoking Prevention Video targeting middle school
age children. Wendell G. Yarbrough, M.D., Carol G. Shores, M.D.,
Ph.D., $10,000.
University Research Council, 1/00-12/01. Cancer Prevention Program,
University of North Carolina. A Controlled Study of the Effectiveness of
a Smoking and Alcohol Prevention Video and Presentation Relating to
Head and Neck Cancer in Middle School Students. Wendell G.
Wendell G. Yarbrough, MD
6
Grants Funded:
Yarbrough, M.D., Adam M. Zanation, Carol G. Shores, M.D., Ph.D.,
$4,000.
AAO-HNS Foundation Resident Research Grant, 7/1/00-6/30/01. The
American Academy of Otolaryngology-Head and Neck Surgery
Foundation, Inc. Cytokeratins as Molecular Markers for Head and Neck
Cancer. Wendell G. Yarbrough, M.D., Mentor. Marta K. Taylor,
Recipient, $10,000.
University Faculty Research Grant, 12/1/99-11/30/01. Efficiency of
Adenovirus Vector-mediated Gene Transfer to Oral Epithelial Cells is
Correlated with Differentiation and Human Coxsackie and Adenovirus
Receptor (hCAR) Expression. Wendell G. Yarbrough, M.D., $620
Lineberger Comprehensive Cancer Center, Translational Research
Award, 7/1/99-6/30/00. p53-independent functions of ARF. Wendell
G. Yarbrough, M.D., $35,000.
Medical Alumni Association Endowment Fund Grant, 7/1/99-6/30/00.
Medical Alumni Association. The tumor suppressive role of the CDK
inhibitors p18 and p27 in ras-mediated epithelial carcinogenesis.
Wendell G. Yarbrough, M.D., Mentor. Mark E. Hutchin, Recipient,
$2,000.
Triological Society Research Training Award, 7/1/99-6/30/00.
Triological Society. Adenoviral mediated ARF overexpression: Effects
on modeled human head and neck mucosa and squamous cell carcinoma.
Wendell G. Yarbrough, M.D., Mentor. Carol G. Shores, M.D.,Ph.D.,
Recipient, $25,000.
Triological Society Research Training Award, 7/1/97-6/30/98.
Triological Society. p16α and p16β expression in head and neck
squamous cell carcinoma: Effects on proliferation and apoptosis.
Wendell G. Yarbrough, M.D., Mentor. Rudolph Triana, M.D.,
Recipient, $25,000.
UNC Lineberger Comprehensive Cancer Center Clinical/Translational
Research Award, 4/1/97-3/31/98. Lineberger Comprehensive Cancer
Center. p16α and p16β as therapeutic targets in head and neck squamous
cell carcinoma. Wendell G. Yarbrough, M.D., Principal Investigator,
$25,000.
Supplemental Grant Lineberger Comprehensive Cancer Center, 9/30/969/29/97. National Cancer Institute. Genetic predisposition to head and
neck squamous cell carcinomas: Role of p16. Wendell G. Yarbrough,
Wendell G. Yarbrough, MD
7
Grants Funded:
M.D., Principal Investigator, $105,202.
K08, National Cancer Institute. Mentored Clinical Scientist
Development Award (K-08), 3/1/97-2/28/02. p16 in head and neck
squamous cell carcinogenesis. Wendell G. Yarbrough, M.D., Principal
Investigator, Edison T. Liu, M.D., and Yue Xiong, Ph.D., Co-Mentors,
$411,761.
Clinical Oncology Career Development Award (CDA), 7/1/96-2/28/97.
American Cancer Society. p16, the G1 cyclin dependent kinase
inhibitor in the pathogenesis of head and neck squamous cell
carcinomas. Wendell G. Yarbrough, M.D., Principal Investigator,
Edison T. Liu, M.D., Sponsor, $90,000.
Academy Research Training Award, 7/1/94-6/30/95. American
Academy of Otolaryngology/Head and Neck Surgery. EMS1
amplification, expression and phosphorylation in head and neck
squamous cell carcinomas. Wendell G. Yarbrough, M.D., Principal
Investigator, $15,000.
Administrative and Teaching Responsibilities:
Preceptor to Carol Shores awarded the 1996 The American Laryngological, Rhinological, and
Otological Society, Inc, Resident Research Award 1st prize for “Evaluation of pre-lingual deafness in
the new millennium”.
Preceptor to Carol Shores awarded The G. Slaughter Fitzhugh Award for Resident Research The
American Laryngological, Rhinological, and Otological Society, Inc, for “Three dimensional
xenograft model of dysplastic human laryngeal mucosa”, 1996.
Board of Governors, American Academy of Otolaryngology/Head and Neck Surgery, 1998-2002.
Member- Sleep Disorders Subcommittee, American Academy of Otolaryngology/Head and Neck
Surgery, 1998-2001.
Co-director- Otolaryngology/Head and Neck Resident Curriculum. University of North Carolina at
Chapel Hill, School of Medicine 1999-2003.
Preceptor to Marta Taylor Becker awarded the resident research award for “Cytokeratins as Molecular
Markers for Head and Neck Cancer” at the annual meeting of the North Carolina/South Carolina
Society of Otolaryngology/Head and Neck Surgery, 2000.
Preceptor to Mark Hutchin awarded the Deborah Leary Award for the Outstanding Medical Student
Research Paper, May 2000.
Wendell G. Yarbrough, MD
Administrative and Teaching Responsibilities:
Preceptor to Adam Zanation awarded Michiko Kuno Research Award for Outstanding Slide
Presentation, “Three Dimensional Raft Modeling of Human Head and Neck Squamous Cell Cancer”,
John B. Graham Student Research Day, January 2001.
Preceptor to Adam Zanation awarded American Association for Cancer Research Novartis Scholar-inTraining Award, “Three Dimensional Raft Modeling of Human Head and Neck Squamous Cell
Cancer”, January 2001.
Preceptor to Jonathan Moss awarded the Holderness Fellowship, “Familial tumor syndrome associated
with a germline p16INK4a mutation”, 2001-2002.
Guest Examiner, American Board of Otolaryngology, April 2001, April 2002.
Preceptor to Kathy Yu awarded the John E. Bordley Award for Outstanding Resident Research
Presentation, “Familial Head and Neck Cancer: Molecular Analysis of a New Clinical Entity”,
Southern Section American Laryngological, Otological, and Rhinological Society, January 2002.
Preceptor to Jonathan Moss awarded Michiko Kuno Research Award for Outstanding Slide
Presentation, “Familial Lung and Head and Neck Cancer Syndrome: Molecular Analysis of a New
Clinical Entity”, John B. Graham Student Research Day, January 2002.
Ad Hoc Reviewer, AAO/HNS Foundation’s Centralized Otolaryngology Research Efforts (CORE),
2002.
Member, American College of Surgeons Oncology Group Basic Science Committee 2002-2005.
Ad Hoc Reviewer, Cancer Molecular Pathobiology (CAMP) Study Section, NIH, 2003-2008.
Member, Prevention Committee of the American Head and Neck Society, 2003-2010.
Member, Research Committee of the American Head and Neck Society, 2003-2005.
Senior Examiner, American Board of Otolaryngology, 2004-2008.
American Head and Neck Society Representative to the AAO/HNS Foundation’s Centralized
Otolaryngology Research Efforts (CORE), 2004-present.
Ad Hoc Reviewer, ZRG1 ONC-Q/Basic Mechanisms of Cancer Therapeutics (BMCT) Special
Emphasis Panel, NIH, 2004.
Member, Head & Neck Surgery and Oncology Committee, American Academy of
Otolaryngology/Head and Neck Surgery, 2004-present.
Member, American Cancer Society Institutional Research Grant Committee, 2004-present.
8
Wendell G. Yarbrough, MD
9
Administrative and Teaching Responsibilities:
Ad Hoc Reviewer, ZDE1 PZ (65) Special Emphasis Panel/Scientific Review Group, NIH, 2005, 2006.
Reviewer, American College of Surgeons, ACS/AHNS Faculty Career Development Award for
Oncology of the Head and Neck 2004, 2005.
Consultant, Research Advisory Committee, American Academy of Otolaryngology/Head and Neck
Surgery, 2006-2008.
Ad Hoc Reviewer, ZRG1 Onc-L (02)M Oncological Sciences Review Group, NIH, 2006.
Ad Hoc Reviewer, Cancer Research UK, 2007.
Member, Head and Neck Surgery Education Committee, American Academy of Otolaryngology-Head
and Neck Surgery, 2007-2009.
Member, Head and Neck Surgery and Oncology Committee, American Academy of OtolaryngologyHead and Neck Surgery, 2007-2010.
Reviewer, DSR NIDCR Special Grants Review Committee (Career Development and Early Career
Awards), 2007-2010.
Patient Safety Officer, Department of Otolaryngology, Vanderbilt University, 2009.
Director, Quality and Patient Safety, Department of Otolaryngology, Vanderbilt University, 2009present.
Board of Scientific Counselors, NIDCD, NIH, Ad Hoc Reviewer, 2010.
External Review Board for Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX,
2010.
Head and Neck Surgery & Oncology Committee, AAO-HNS/F as a Member from 10/1/2004 to
9/30/2010.
Clinical Trials:
Institutional Principal Investigator
A randomized phase 3 trial of intratumoral injection of CI-1042
(ONYX-015) plus intravenous cisplatin/5-fluorouracil versus
intravenous cisplatin/5-fluorouracil alone in patients with
recurrent squamous cell carcinoma of the head and neck
(protocol 1042-001). Sponsor: Pfizer/ONYX Pharmaceuticals
11/2000-2/2003.
Wendell G. Yarbrough, MD
10
Clinical Trials:
Institutional Principal Investigator
An open label, single arm study of intratumoral ONYX-015 plus
intravenous cisplatin/5-FU in patients with squamous cell
carcinoma of the head and neck (SCCHN) refractory to
cisplatin/5-FU. Sponsor: ONYX Pharmaceuticals 10/20022/2003.
Institutional Principal Investigator
A trial of lymphatic mapping and sentinel node
lymphadenectomy for patients with T1 or T2 clinically N0 oral
cavity squamous cell carcinoma. Sponsor: American College of
Surgeons Oncology Group (ACOSOG) 2/2002-4/2003
University of North Carolina at Chapel Hill.
Institutional Principal Investigator
A trial of lymphatic mapping and sentinel node
lymphadenectomy for patients with T1 or T2 clinically N0 oral
cavity squamous cell carcinoma. Sponsor: American College of
Surgeons Oncology Group (ACOSOG) 1/2004- 5/2006
Vanderbilt University.
Institutional Principal Investigator
Comparison of biomarker modulation by inhibition of EGFR
and/or src family kinases using Erlotinib and Dasatinib in head
and neck and lung cancers. Sponsor: NIH 3/2010-present
Vanderbilt University.
Institutional Co-Investigator
Randomized phase II trial of everolimus vs. placebo as adjuvant
therapy in patients with locally advanced squamous cell cancer
of the head and neck (SCCHN). Sponsor: NCI as an
interSPORE. 4/2010-present Vanderbilt University.
Editorial Boards:
2007 – 2010
Head & Neck
Invited Journal Review:
Annals of Surgical Oncology
Archives of Otolaryngology-Head and Neck Surgery
Briefings in Functional Genomics and Proteomics
Cancer
Cancer Research
Clinical Cancer Research
Head & Neck
Journal of Clinical Oncology
Journal of Medical Genetics
Wendell G. Yarbrough, MD
Invited Journal Review:
Journal of the National Cancer Institute
Laryngoscope
Lasers in Surgery & Medicine
Molecular Cancer Therapeutics
Molecular Carcinogenesis
Molecular Medicine
Nature Genetics
Oncogene
Otolaryngology-Head and Neck Surgery
Proceedings of the National Academy of Science (PNAS)
Tumor Biology
Publications (In Press):
1.
Publications (In Peer-Reviewed Journals):
1. Wilson EM, Wright BT, Yarbrough WG. The possible role of disulfide bond reduction in
transformation of the 10S androgen receptor. The Journal of Biological Chemistry
261(14):6501-8; 15 May 1986. PMID: 3700403.
2. Joseph DR, Hall SH, Yarbrough WG, Conti M, French FS. Structure of the rat androgenbinding protein gene. Annals of the New York Academy of Sciences 538:30-36; 1988. PMID:
3190083.
3. Wang YM, Sullivan PM, Petrusz P, Yarbrough WG, Joseph DR. The androgen-binding
protein gene is expressed in CD1 mouse testis. Molecular and Cellular Endocrinology 63:8592; 1989. PMID: 2753230.
4. Quarmby VE, Yarbrough WG, Lubahn DB, French FS, Wilson EM. Autologous downregulation of androgen receptor messenger ribonucleic acid. Molecular Endocrinology 4(1):228; Jan 1990. PMID: 2325667.
5. French FS, Lubahn DB, Brown TR, Simental JA, Quigley CA, Yarbrough WG, Tan JA, Sar M,
Joseph DR, Evans BAJ, Hughes IE, Migeon CJ, Wilson EM. Molecular basis of androgen
insensitivity. Recent Progress in Hormone Research 46:1-38; discussion 38-42; 1990. Review.
PMID: 2281183.
6. Yarbrough WG, Quarmby VE, Simental JA, Joseph DR, Sar M, Lubahn DB, Olsen KL, French
FS, Wilson EM. A single base mutation in the androgen receptor gene causes androgen
insensitivity in the testicular feminized rat. The Journal of Biological Chemistry 265(15):893900; 25 May 1990. PMID: 2341409.
11
Wendell G. Yarbrough, MD
Publications (In Peer-Reviewed Journals):
7. Lubahn DB, Simental JA, Quigley CA, Yarbrough WG, Charest NJ, Harris SE, Hughes IA,
Brown TR, Migeon CJ, Sar MA, Zhou ZX, Tan JA, Wilson EM, French FS. Sequence analysis
and biological expression of in vivo androgen receptor gene mutations. Serono Symposia
Publications Vol 71 Reproductive Growth and Development Negro-Vilar A., Perez-Palacios G.
(eds) pp163-164, 1991.
8. Yarbrough WG, Brownlee RE, Pillsbury HC. Primary anastomosis of extensive facial nerve
defects: an anatomic study. American Journal of Otology 14(3):238-46; May 1993. PMID:
8372920.
9. Yarbrough WG, Shores C, Witsell D, Fidler M, Weissler MC, Gilmer TM. ras mutations and
expression in head and neck squamous cell carcinomas. Laryngoscope 104(11 Pt 1):1337-47;
Nov 1994. PMID: 7968162.
10. Witsell DL, Yarbrough WG, Garrett CG, Weissler MC. Treatment of isolated laryngeal
blastomycosis with ketoconazole. North Carolina Med J 55(12):588-90; Dec 1994. PMID:
7854464.
11. McQueen CT, Yarbrough WG, Witsell DL, Holmes DK, Shockley WW. Unilateral
supraglottis in adults: Fact or fiction. The Journal of Otolaryngology 24(4):255-7; Aug 1995.
PMID: 8551540.
12. Witsell DL, Garrett CG, Yarbrough WG, Dorrestein SP, Drake AF, Weissler MC. Effect of
Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: a prospective
randomized trial. Journal of Otolaryngology 24(4):230-3; Aug 1995. PMID: 8551535.
13. Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET. Familial tumor syndrome
associated with a germline non-functional p16INK4a allele. Journal of the National Cancer
Institute 88(20):1489-91; 16 Oct 1996. PMID: 8841025.
14. Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB, Yarbrough WG.
Alterations of the p16 gene in head and neck cancer: Frequency and association with p53,
PRAD-1, and HPV. Oncogene 14(7):811-8; 20 Feb 1997. PMID: 9047388.
15. Zhang Y, Xiong Y, Yarbrough WG. ARF Promotes MDM2 Degradation and Stabilizes p53:
ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways. Cell
92(6):725-34; 20 Mar 1998. PMID: 9529249.
16. Shores CG, Yarbrough WG. Three dimensional xenograft model of dysplastic human
laryngeal mucosa. Laryngoscope 108(9):1358-62; Sep 1998. PMID: 9738757.
17. Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey
MF, Thatcher N, Yarbrough WG, Betticher DC. Expression of p16INK4/p16 and
p19ARF/p16 is frequently altered in non-small cell lung cancer and correlates with p53
overexpression. Oncogene 17(21):2779-85; 26 Nov 1998. PMID: 9840942.
12
Wendell G. Yarbrough, MD
Publications (In Peer-Reviewed Journals):
18. Yarbrough WG, Buckmire RA, Bessho M, Liu ET. Biologic and Biochemical Analyses of
p16INK4a Mutations from Primary Tumors. Journal of the National Cancer Institute
91(18):1569-74; 15 Sep 1999. PMID: 10491434.
19. Hutchin ME, Shores CG, Bauer MS, Yarbrough WG. Sinogenic Subdural Empyema and
Streptococcus anginosus. Archives of Otolaryngology-Head and Neck Surgery 125(11):12626; Nov 1999. PMID: 10555700.
20. Labadie RF, Yarbrough WG, Weissler MC, Pillsbury HC, Mukherji SK. Nodal volume
reduction in head and neck squamous cell carcinoma after concurrent chemo- and
radiotherapy: Correlation between CT and histopathologic findings. American Journal of
Neuroradiology 21(2):310-4; Feb 2000. PMID: 10696014.
21. Yarbrough WG. Response to Re: Biologic and Biochemical Analyses of p16INK4a Mutations
From Primary Tumors. Journal of the National Cancer Institute 92(9):759-60; 3 May 2000.
PMID: 10793121.
22. Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA,
Tanaka N, Kodama M. Induction of apoptosis in human esophageal cancer cells by sequential
transfer of the wild-type p53 and E2F1 genes: Involvement of p53 accumulation via ARFmediated MDM2 down-regulation. Clinical Cancer Research 6(7):2851-9; Jul 2000. PMID:
10914734.
23. Hutchin ME, Gilmer C, Yarbrough WG. Delayed-Onset Sensorineural Hearing Loss in a 3Year-Old Survivor of Persistent Pulmonary Hypertension of the Newborn. Archives of
Otolaryngology 126(8):1014-7; Aug 2000. PMID: 10922237.
24. Hutchin ME, Pickles, RJ, Yarbrough WG. Efficiency of Adenovirus-mediated Gene Transfer
to Oropharyngeal Epithelial Cells Correlates with Cellular Differentiation and Human
Coxsackie and Adenovirus Receptor (hCAR) Expression. Human Gene Therapy 11(17):236575; 20 Nov 2000. PMID: 11096441.
25. Ferguson M, Smith TL, Zanation AM, Yarbrough WG. Radiofrequency tissue volume
reduction: Multilesion vs single-lesion treatments for snoring. Archives of OtolaryngologyHead & Neck Surgery 127(9):1113-8; Sep 2001. PMID: 11556863.
26. Tschan MP, Vonlanthen S, Cajot JF, Peters UR, Oppliger E. Betticher DC, Yarbrough WG,
Fey MF, Tobler A. Different p16INK4a and p14ARF expression patterns in acute myeloid
leukaemia and normal blood leukocytes. Leukemia and Lymphoma 42(5):1077-87; Sep-Oct
2001. PMID: 11697625.
27. Poole ME, Sailer SL, Rosenman JG, Tepper JE, Weissler MC, Shockley WW, Yarbrough WG,
Pillsbury III HC, Schell MJ, Bernard SA. Chemoradiation for Locally Advanced Squamous
Cell Carcinoma of the Head and Neck for Organ Preservation and Palliation. Archives of
13
Wendell G. Yarbrough, MD
Publications (In Peer-Reviewed Journals):
Otolaryngology-Head & Neck Surgery 127(12):1446-50; Dec 2001. PMID: 11735812.
28. Yarbrough WG, Bessho M, Zanation A, Bisi JE, Xiong Y. Human Tumor Suppressor ARF
Impedes S-phase Progression Independent of p53. Cancer Research 62(4):1171-7; 15 Feb
2002. PMID: 11861400.
29. Yu KK, Zanation AM, Moss JR, Yarbrough WG. Familial head and neck cancer: Molecular
analysis of a new clinical entity. Laryngoscope 112(9):1587-93; Sep 2002. PMID: 12352668.
30. Yarbrough WG. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck
squamous cell carcinoma. Laryngoscope 112(12):2114-28; Dec 2002. PMID: 12461329.
31. Mauser A, Holley-Guthrie E, Zanation A, Yarbrough WG, Kaufmann W, Klingelhutz A,
Seaman WT, Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 induces
expression of E2F-1 and other proteins involved in cell cycle progression in primary
keratinocytes and gastric carcinoma cells. Journal of Virology 76:12543-12552; 2002. PMID:
12438580.
32. Brinson GM, Senior BA, Yarbrough WG. Endoscopic management of retained airgun
projectiles in the paranasal sinuses. Otolaryngology-Head and Neck Surgery 130(1):25-30; Jan
2004. PMID: 14726907.
33. Becker MT, Shores CG, Yu KK, Yarbrough WG. Molecular assay to detect metastatic head
and neck squamous cell carcinoma. Archives of Otolaryngology Head and Neck Surgery
130(1):21-7; Jan 2004. PMID: 14732763.
34. Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, Butterfoss D, Xiang D,
Zanation A, Yin X, Shockley WW, Weissler MC, Dressler LG, Shores CG, Yarbrough WG,
Perou CM. Molecular classification of head and neck squamous cell carcinomas using patterns
of gene expression. Cancer Cell 5(5):489-500; May 2004. PMID: 15144956.
35. Shores CG, Yin X, Funkhouser W, Yarbrough WG. Clinical evaluation of a new molecular
method for detection of micrometastases in head and neck squamous cell carcinoma. Archives
of Otolaryngology Head and Neck Surgery 130:937-942, 2004. PMID: 15313863.
36. Zanation AM, Yin X, Shores C, Yarbrough WG. Phenotypic and microarray gene expression
analysis of tri-dimensional raft modeled human head and neck squamous cell carcinoma.
Otolaryngology-Head and Neck Surgery 131(5):577-84; Nov 2004. PMID: 15523429.
37. Wang J, He X, Luo Y, Yarbrough WG. A novel ARF-binding protein (LZAP) alters ARF
regulation of HDM2. Biochem J 393(Pt 2):489-501; 15 Jan 2006. PMID: 16173922.
38. Slebos RJC, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ,
Burkey BB, Netterville JL, Levy S, Yarbrough WG, Chung CH. Gene expression differences
associated with HPV status in head and neck squamous cell carcinoma. Clinical Cancer
14
Wendell G. Yarbrough, MD
Publications (In Peer-Reviewed Journals):
Research 12:701-709; 2006. PMID: 16467079.
39. Chung CH, Levy S, Yarbrough WG. Clinical application of genomics in head and neck cancer.
Head and Neck 28(4): 360-368; 2006. PMID: 16284976.
40. Yarbrough WG, Slebos RJC, Liebler D. Proteomics: Clinical applications for head and neck
squamous cell carcinoma. Head and Neck 28(6): 549-558; 2006. PMID: 16475197.
41. Whigham AS, Netterville JL, Burkey BB, Sinard RJ, Chung CH, Slebos RJC, Yarbrough WG.
Short-term culture and in vivo modeling of primary head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg 132(8): 901-902, 2006. PMID: 19693929.
42. Stacy DR, Ely K, Massion PP, Yarbrough WG, Hallahan DE, Sekhar KR, Freeman ML.
Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck
squamous cell carcinomas. Head and Neck 28: 813-818; 2006. PMID: 16637057.
43. Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar A, Zanation
AM, Cmelak AJ, Levy S, Slebos RJ, Yarbrough WG. Gene expression profiles identify
epithelial-to mesenchymal transition and activation of nuclear factor-B signaling as
characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Research
66(16): 8210-8218; 2006. PMID: 16912200.
44. Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J,
Murphy BA, Netterville JN, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos
RJ, and Hirsch FR. Increased epidermal growth factor receptor gene copy number is associated
with poor prognosis in head and neck squamous cell carcinomas. Journal of Clinical Oncology
24(25): 4170-4176; 2006. PMID: 16943533.
45. Slebos RJC, Li M, Evjen AN, Coffa J, Shyr Y, Yarbrough WG. Mutagenic effect of cadmium
on tetranucleotide repeats in human cells. Mutat Res 602(1-2):92-9; 1 Dec 2006. PMID:
16989872.
46. Clark ES, Whigham AS, Yarbrough WG, Weaver AM. Cortactin is an essential regulator of
matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
Cancer Res 67(9):4227-35; 1 May 2007. PMID: 17483334.
47. Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG. LZAP, a putative tumor suppressor
selectively inhibits NF-B. Cancer Cell 12(3):239-51; Sep 2007. PMID: 17785205.
48. Yarbrough WG, Whigham A, Brown B, Roach M, Slebos R. Phosphoinositide kinase-3 status
is associated with the presence or absence of human papilloma virus in head and neck
squamous cell carcinomas. Int J Radiat Oncol Biol Phys 69(2 Suppl):S98-101; 2007. PMID:
17848307.
49. Slebos RJC, Li M, Vadivelu S, Burkey BB, Netterville JL, Sinard R, Gilbert J, Murphy B,
15
Wendell G. Yarbrough, MD
Publications (In Peer-Reviewed Journals):
Chung CH, Yarbrough WG. Microsatellite mutations in buccal cells are associated with aging
and head and neck carcinoma. Br J Cancer 98(3):619-26; 12 Feb 2008. PMID: 18212747.
50. Gilbert J, Cmelak A, Shyr Y, Netterville J, Burkey BB, Sinard RJ, Yarbrough WG, Chung
CH, Aulino JM, Murphy BA. Phase II trial of irinotecan plus cisplatin in patients with
recurrent or metastatic squamous carcinoma of the head and neck. Cancer 113(1):186-92; 1 Jul
2008. PMID: 18484593.
51. Mukherjee K, Cash MP, Burkey BB, Yarbrough WG, Netterville JL, and Melvin WV.
Antegrade and retrograde endoscopy for treatment of esophageal stricture. Am Surg 74(8):6867; discussion 688; Aug 2008. PMID: 18705567.
52. Clark ES, Brown B, Whigham AS, Kochiashvili A, Yarbrough WG, Weaver A.
Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the
11q13 amplicon. Oncogene 28(3):431-44; 22 Jan 2009. PMID: 18931703.
53. Baumann JL, Cohen S, Evjen AN, Law JH, Vadivelu S, Attia A, Schindler JS, Chung
CH, Wirth PS, Meijer CJ,Snijders PJ, Yarbrough WG, Slebos RJ. Human papillomavirus in
early laryngeal carcinoma. Laryngoscope 119(8):1531-1537; 2009. PMID: 19489068.
54. Yang ES, Murphy BM, Chung CH, Netterville JL, Burkey BB, Gilbert J, Yarbrough WG,
Sinard R, Cmelak AJ. Evolution of clinical trials in head and neck cancer. Crit Rev Oncol
Hematol 71(1):29-42; Jul 2009. PMID: 18996026.
55. Law JH, Whigham AS, Wirth PS, Liu D, Pham MQ, Vadivelu S, Kirkbride KC, Brown BT,
Burkey BB, Sinard RJ, Netterville JL, Yarbrough WG. Human-in-mouse modeling of primary
head and neck squamous cell carcinoma. Laryngoscope 119(12):2315-23; Dec 2009. PMID:
19693929.
56. Murphy Barbara A, Dietrich Mary S, Wells Nancy, Dwyer Kathleen, Ridner Sheila H, Silver
Heidi J, Gilbert Jill, Chung Christine H, Cmelak Anthony, Burkey Brian, Yarbrough Wendell
G, Sinard Robert, Netterville James. Reliability and Validity of the Vanderbilt Head and Neck
Symptom Survey: A Tool to Assess Symptom Burden in Patients Treated with
Chemoradiation. Head & Neck 32(1): 26-37; 2010. PMID: 19626644.
57. Civantos FJ, Zitsch RP, Schuller DE, Agrawal A, Smith RB, Nason R, Petruzelli G, Gourin
CG, Wong RJ, Ferris RL, El Naggar A, Ridge JA, Paniello RC, Owzar K, McCall L, Chepeha
DB, Yarbrough WG, Myers JN. Sentinel lymph node biopsy accurately stages the regional
lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multiinstitutional trial. J Clin Oncol 28(8):1395-400; 10 Mar 2010. PMID: 20142602.
58. Chung CH, Aulino J, Muldowney NJ, Hatakeyama H, Baumann J, Burkey B, Netterville J,
Sinard R, Yarbrough WG, Cmelak AJ, Slebos RJ, Shyr Y, Parker J, Gilbert J, Murphy BA.
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in
patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Annals of
16
Wendell G. Yarbrough, MD
17
Publications (In Peer-Reviewed Journals):
Oncology 21(4):864-70; Apr 2010. PMID: 19850643.
59. Hartert TV, Carroll K, Gebretsadik T, Woodward K, Minton P, Environmental Health
Research Investigators. The Tennessee Children's Respiratory Initiative: Objectives, design
and recruitment results of a prospective cohort study investigating infant viral respiratory
illness and the development of asthma and allergic diseases. Respirology 15:691-699; 2010.
PMID: 20409023.
60. Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH,
Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ. Hypothyroidism as a
Consequence of Intensity-Modulated Radiotherapy with Concurrent Taxane-Based
Chemotherapy for Locally Advanced Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys
77(2):468-76; 1 Jun 2010. PMID: 19577867.
61. Li M, Gray W, Zhang H, Chung CH, Billheimer D, Yarbrough WG, Liebler DC, Shyr Y,
Slebos RJ. Comparative shotgun proteomics using spectral count data and quasi-likelihood
modeling. J Proteome Res. 2010 Jun 29. [Epub ahead of print] PMID: 20586475.
Book Chapters:
1. Yarbrough WG, Weissler MC. Coagulation and Hemostasis. In Weissler M.C. Complications
of head and neck surgery. Thieme Medical Publishers, Inc., New York, N.Y.,1995, pp. 5-30.
2. Drake AF, Yarbrough WG. True vocal cord injection for paralysis. In Bailey BJ et al, Atlas of
head and neck surgery - Otolaryngology. JB Lippincott, Philadelphia, 1996, pp. 174-75.
3. Yarbrough WG, Xiong Y. p16 and ARF: Crossroads of Tumorigenesis, In Bertino, J.R.
Encyclopedia of Cancer. Academic Press, San Diego, 2002, vol III pp. 491-505.
4. Whigham AS, Yarbrough WG. Prediction of Nodal Metastases from Genomic Analyses of the
Primary Tumor. In Myers J. Oral Cancer Metastasis. Springer, New York, 2009, pp75-104.
National/Invited Presentations: (see Honors and Awards, or no longer kept)
Honors and Awards:
1981-1985
John Motley Morehead Scholarship, University of North Carolina, Chapel
Hill
1982
Phi Eta Sigma (Freshman Honor Society)
1984
Phi Beta Kappa
Wendell G. Yarbrough, MD
18
Honors and Awards:
1985
1985
Student Research & Recognition Foundation Award, Recognizing
Outstanding Senior Student Majoring in Chemistry
Phi Lambda Upsilon (Honorary Chemical Society)
1985
Graduation with Honors in Chemistry
1986-1989
Academic Honors, Medical School
1988
Alpha Omega Alpha
1989
Michiko Kuno Award for Best Presentation of John B. Graham Student
Research Society
1989
Deborah C. Leary Award for the outstanding medical student research paper
1989
Graduation with Honors and Distinction, University of North Carolina School
of Medicine
1991, 1992
Newton D. Fischer Society Temporal Bone Dissection Award
1994
The American Laryngological, Rhinological, and Otological Society, Inc.,
Resident Research Award, 1st prize
1994
Nathan A. Womack Scholar, recognizing the outstanding surgical resident at
the University of North Carolina Hospitals
2000
Jefferson Pilot Fellowship recognizing the outstanding Assistant Professor in
the School of Medicine at the University of North Carolina at Chapel Hill
2002
The American Laryngological, Rhinological, and Otological Society Harris P.
Mosher Award recognizing excellence in clinical research
2004
Distinguished Service Award in Scientific Programs, Exhibits, Continuing
Education Courses and Instructional Course, American Academy of
Otolaryngology-Head and Neck Surgery Foundation.
2005
Visiting Professor, MD Anderson Cancer Center, Division of
Otolaryngology.
2005
Visiting Professor, University of Michigan, Department of Otolaryngology.
2005
Visiting Professor, Medical University of South Carolina, Department of
Otolaryngology.
Wendell G. Yarbrough, MD
19
Honors and Awards:
2008
Invited Speaker, University of Louisville, Poa Pratensis Molecular Targets
Program, Louisville, KY.
2008
Invited Speaker/Panel Moderator, "Asking the Critical Questions in WellDifferentiated Thyroid Cancer," AAO-HNS Annual Meeting and Oto Expo,
Chicago, IL, September 21-24, 2008.
Visiting Professor Department of Otolaryngology, UNC School of Medicine,
Chapel Hill, NC.
2009
2009
Guest Lecturer for 2009 Resident Recognition Day, Emory University,
Atlanta, GA.
2009
Guest Lecturer, "HNSCC: Viruses, Vaccines, and Therapy," 18th Annual
HIV/STD Conference, September 23-25, 2009, Springfield, IL.
2010
Visiting Professor, "Head & Neck Program and Baker Lab Overview,"
Comprehensive Cancer Center, The University of Alabama at Birmingham,
Birmingham, GA.
2010
Guest Lecturer, "Head & Neck Program and Baker Lab Overview,"
Department of Surgery Grand Rounds Lecture, Meharry Medical College,
Nashville, TN.
Community
Outreach:
April 11 - 17, 2005.
Screening April 15.
Head and Neck Cancer Awareness Week (national organization: Yul Brynner
Head and Neck Cancer Foundation).
April 17 - 23, 2006.
Screening April 21.
Head and Neck Cancer Awareness Week (national organization: Yul Brynner
Head and Neck Cancer Foundation).
April 16 - 22, 2007.
Screening April 20.
Head and Neck Cancer Awareness Week (national organization: Yul Brynner
Head and Neck Cancer Foundation).
August 9, 2007.
Bobby Hamilton Racing Open House (Bobby Hamilton Racing, Mt. Juliet,
TN).
2008 - 2009
Volunteered at Siloam clinic, Siloam Family Health Center (cares for the
uninsured in Middle Tennessee).
April 21 - 27, 2008.
Screening April 25.
Head and Neck Cancer Awareness Week (national organization: Yul Brynner
Head and Neck Cancer Foundation).
Wendell G. Yarbrough, MD
20
Community
Outreach:
April 27 - May 3,
2009. Screening May
1.
Oral, Head and Neck Cancer Awareness Week (national organization: Head
and Neck Cancer Alliance).
July 11, 2009.
Church of Christ at Jackson Streeth Health Fair (Church of Christ at Jackson
Street, Nashville, TN).
September 30, 2009.
World of Bluegrass Convention Health Fair (Nashville Convention Center,
Nashville, TN).
March 27, 2010.
WellFEST For the Deaf and Hard of Hearing (Nashville Public Library,
Nashville, TN).
April 12 - 18, 2010.
Screening April 16.
Oral, Head and Neck Cancer Awareness Week (national organization: Head
and Neck Cancer Alliance).
April 20, 2010.
Vanderbilt Employee Health Fair (Vanderbilt University, Nashville, TN).
Past and Present Trainees:
Position During Training
Residents
Degree(s)
Current Position
Rudolph Triana (1998)
MD
Carol G. Shores (1999)
MD/PhD
Robert A. Buckmire (1999)
MD
Marta T. Becker (2001)
MD
Kathy K. Yu (2002)
MD
Seth Cohen (2005)
MD
Amy Whigham (2007)
MD
Nicholas Stowell (2009)
MD
Benjamin Johnston (20092010)
Yong Cha (2010-2013)
MD
Private Practice Otolaryngology/Head and Neck
Surgery, Owensville, Kentucky
Assistant Professor Otolaryngology/Head and Neck
Surgery, University of North Carolina, Chapel Hill, NC
Assistant Professor Otolaryngology/Head and Neck
Surgery, University of North Carolina, Chapel Hill, NC
Private Practice Otolaryngology/Head and Neck
Surgery, Philadelphia, PA
Private Practice Otolaryngology/Head and Neck
Surgery, Chapel Hill, NC
Assistant Professor Otolaryngology, Duke University,
Durham, NC
Resident Otolaryngology, Vanderbilt University
Medical School, Nashville, TN
Resident Otolaryngology, Vanderbilt University
Medical School, Nashville, TN
Resident Otolaryngology, Vanderbilt University
Medical School, Nashville, TN
Resident, B. Leonard Holman Research Pathway,
American Board of Radiology, 2009-2013
MD, PhD
Wendell G. Yarbrough, MD
21
Past and Present Trainees:
Position During Training
Medical/Graduate Students
Degree(s)
Current Position
Mark E. Hutchin (1999)
Adam M. Zanation (2001)
BS
BS
Jonathan R. Moss (2002)
BA
Jialiang Wang (2000)
BA
William Wood (2002)
BA
Xinyuan Lu (2007)
Dan Liu (2008)
Jonathan Law (2008)
BA
BA
MD
Private Practice Dermatology, Asheville, NC
Assistant Professor Otolaryngology, University of
North Carolina, Chapel Hill, NC
Resident Otolaryngology/Head and Neck Surgery,
Vanderbilt University Medical School, Nashville, TN
Post Doctoral Fellow, Duke University, Durham, North
Carolina
Resident Otolaryngology/Head and Neck Surgery,
University of Pittsburgh, Pittsburgh, PA
Graduate Student, Vanderbilt University, Nashville, TN
Graduate Student, Vanderbilt University, Nashville, TN
Resident Otolaryngology/Head and Neck Surgery,
Washington University School of Medicine, St. Louis,
MO
Past and Present Trainees:
Position During Training
Post doctoral/clinical fellows
Degree(s)
Current Position
Evjeniy Petrochenko (2000)
PhD
Jialiang Wang (2007)
PhD
Hanbing An (2005)
PhD
Andrew Wilson (2008)
PhD
Zhirong Yin (2009)
PhD
Post Doctoral Fellow, University of North Carolina,
Chapel Hill, NC
Post Doctoral Fellow, Duke University Medical Center,
Durham, NC
Research Fellow, Vanderbilt University Medical
School, Nashville, TN
Research Instructor, Vanderbilt University Medical
School, Nashville, TN
Research Fellow, Vanderbilt University Medical
School, Nashville, TN
Past and Present Trainees:
Position During Training
Faculty
Degree(s)
Current Position
Christine Chung (2002)
MD
Robbert Slebos (2003)
PhD
Assistant Professor Medicine (Hem/Onc), Vanderbilt
University Medical School, Nashville, TN
Research Assistant Professor Cancer Biology,
Vanderbilt University Medical School, Nashville, TN
Wendell G. Yarbrough, MD
22
Past and Present Trainees:
Position During Training
Faculty
Degree(s)
Current Position
Sabina Francis (2004)
MD
Dana Marshall (2006)
PhD
Assistant Professor Surgery (Otolaryngology), Meharry
Medical College, Nashville, TN
Assistant Professor Surgery, Meharry Medical College,
Nashville, TN
Honors/Awards of Trainees While in Training:
Rudolph Triana
Triological Society Research Training Award, 7/1/97-6/30/98.
Carol G. Shores
Triological Society Research Training Award, 7/1/99-6/30/00.
The G. Slaughter Fitzhugh Award for Resident Research. The
American Laryngological, Rhinological, and Otological Society,
Inc., 1996.
Resident Research Award 1st prize. The American Laryngological,
Rhinological, and Otological Society, Inc., 1999.
Marta T. Becker
AAO-HNS Foundation Resident Research Grant, 7/1/00-6/30/01.
North Carolina/South Carolina Society of Otolaryngology/Head and
Neck Surgery Resident Research Award, 2000.
Mark E. Hutchin
Medical Alumni Association Endowment Fund Grant. UNC School
of Medicine, 7/1/99-6/30/00.
Deborah Leary Award for the Outstanding Medical Student
Research Paper. UNC School of Medicine, May 2000.
Adam M. Zanation
Scott Neil Schwirck Fellowship. UNC School of Medicine, 1/1/01–
1/01/02.
Alpha Omega Alpha Research Fellowship. Alpha Omega Alpha
National Medical Honor Society, 4/1/01-4/1/02.
Medical Alumni Endowment Research Grant. UNC School of
Medicine, 6/1/01-5/31/02.
Doris Duke Clinical Research Fellowship. Doris Duke Charitable
Foundation, 6/1/01- 5/30/02.
American Association for Cancer Research Novartis Scholar-inTraining Award, 2001.
Michiko Kuno Research Award. Outstanding Slide Presentation at
UNC School of Medicine Student Research Day, 2001.
Jonathan Moss
Holderness Fellowship, UNC School of Medicine, 2001-2002.
Michiko Kuno Research Award. Outstanding Slide Presentation at
UNC School of Medicine Student Research Day, 2002.
Wendell G. Yarbrough, MD
23
Honors/Awards of Trainees While in Training:
Kathy Yu
John E. Bordley Award, Southern Section American Laryngological,
Otological, and Rhinological Society for best resident presentation
January 2002.
William Wood
AMA Foundation Seed Grant, American Medical Association
Foundation, March 2003.
Christine Chung
Vanderbilt Physician-Scientist Development Award, July 2003.
Damon Runyon Clinical Investigator, 2005.
R01 funding, 2007.
Dana Marshall
U54 Pilot Project, July 2008. Meharry Vanderbilt Alliance.